Schwarz Pharma AG
Records under this name other than patents Schwarz Pharma AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,670,621 | Transdermal Administration of (R)-3,3-Diphenylpropylamin-MONOESTERS Formerly held In force · High confidence | In force | High confidence | |
| US 7,807,715 | Pharmaceutical compositions comprising fesoterodine Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,095,557 | Anticonvulsant combination therapy Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,446,011 | Anticonvulsant combination therapy Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,982,058 | Chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,246,979 | Transdermal delivery system for the administration of rotigotine Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,088,398 | Pharmaceutical compositions comprising fesoterodine Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,501,723 | Pharmaceutical compositions comprising fesoterodine Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,044,061 | 8-alkynylxanthines and derivatives Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,232,414 | Polymorphic form of rotigotine and process for production Formerly held In force · From the USPTO record | In force | From the USPTO record |